about
Relationships between depressive symptoms and self-reported unintentional injuries: the cross-sectional population-based FIN-D2D surveyHigh prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population.Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial.Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D surveyLifestyle intervention in prevention of type 2 diabetes in women with a history of gestational diabetes mellitus: one-year results of the FIN-D2D project.Association of serum 25-hydroxyvitamin D with lifestyle factors and metabolic and cardiovascular disease markers: population-based cross-sectional study (FIN-D2D)The use of fasting vs. non-fasting triglyceride concentration for estimating the prevalence of high LDL-cholesterol and metabolic syndrome in population surveys.Population-level effects of the national diabetes prevention programme (FIN-D2D) on the body weight, the waist circumference, and the prevalence of obesity.Leisure-time physical activity and the metabolic syndrome in the Finnish diabetes prevention study.Bariatric surgery and long-term cardiovascular events.Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects.Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey.Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D).Leukocyte telomere length in the Finnish Diabetes Prevention Study.Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant.Perceived need to increase physical activity levels among adults at high risk of type 2 diabetes: a cross-sectional analysis within a community-based diabetes prevention project FIN-D2D.High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study.Impact of positive family history and genetic risk variants on the incidence of diabetes: the Finnish Diabetes Prevention Study.Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study.The incidence of albuminuria after bariatric surgery and usual care in Swedish Obese Subjects (SOS): a prospective controlled intervention trial.Impact of health counselling on cardiovascular disease risk in middle aged men: influence of socioeconomic statusIncrease in physical activity and cardiometabolic risk profile change during lifestyle intervention in primary healthcare: 1-year follow-up study among individuals at high risk for type 2 diabetesTwo year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity.Lifestyle strategies for weight control: experience from the Finnish Diabetes Prevention Study.Do statins interfere with lifestyle intervention in the prevention of diabetes in primary healthcare? One-year follow-up of the FIN-D2D project.Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes.Evaluation of current eligibility criteria for bariatric surgery: diabetes prevention and risk factor changes in the Swedish obese subjects (SOS) study.Prevention of type 2 diabetes--lessons we have learnt for implementation.Trends in self-reported sleep duration and insomnia-related symptoms in Finland from 1972 to 2005: a comparative review and re-analysis of Finnish population samples.Sleep duration, lifestyle intervention, and incidence of type 2 diabetes in impaired glucose tolerance: The Finnish Diabetes Prevention Study.Physical activity and sleep profiles in Finnish men and women.Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.Health care use during 20 years following bariatric surgery.Age-period-cohort effects on stroke mortality in Sweden 1969-1993 and forecasts up to the year 2003.Changes in all-cause and cardiovascular disease mortality in three different Finnish population cohorts with and without diabetes.Prevalence, predictors and covariates of functional status impairment among Finnish Second World War veterans during 1992-2004.Determinants of changes in self-rated health among Finnish war veterans: results from the Veteran Project 1992 and 2004 surveys.Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe.Fatty liver and serum cholinesterase are independently correlated with HbA1c levels: cross-sectional analysis of 5384 people.
P50
Q28391364-E04EACD6-DD58-463D-82EE-2A94CE4DD352Q30856424-DDC14106-2AFB-4D15-9284-B796EE486FB4Q33455816-1BC5321C-B428-4764-A973-F9C62AF88A22Q33575324-1C1AEA23-D04A-4B38-9A63-EC84ADA28A6DQ33714426-3B7BD61C-8F93-4F9F-A1A1-CC1AF439CD9EQ33856587-7D4791FE-7C44-4391-8704-7F356DBACB9BQ33898462-7069179F-9DD3-4BF8-B36A-E91BD328C426Q33906103-C05CE409-634E-4EDD-A3A5-111D3B390299Q33932824-FFBCEA95-C244-442F-A3F1-0F66AC842A59Q34030064-DE31FDBA-F366-4D5D-8AD1-FCEEB30883D3Q34033254-E56C9A47-222B-4201-ACE9-1B2B93EBFA69Q34036290-D1B6C1A1-CD1F-4F87-A969-FFF458822A78Q34153413-38482952-4B45-410B-BAB3-B7A0662E7CA7Q34228543-F421B3B5-7DF4-4320-9A10-B417FE80D1D4Q34314416-FB6EE50A-CC00-46FC-ADF0-1F24762D5744Q34332373-19A9610E-CF1F-46DE-A24C-DAB8D6291983Q34502668-DA3D950A-88E1-449B-8ECA-C91D24110380Q34507211-7A685306-A53A-4607-9BEF-E79A29B1B49AQ34580894-9B50917B-097E-460B-AC09-5A9EDD8797EDQ34653992-B8832E40-F758-4B1A-ABBF-CD6CDB9E7294Q34848978-FFEB4243-EBE9-4E78-84D7-12C0C5E28A7FQ35097657-66CFDE88-D8E2-4584-9830-7252E4329940Q35629850-31DE4A9A-D3C0-4C71-B69F-24CDB6A2A9ECQ35995476-F4294248-AC42-440E-8377-76CF78B3A4CAQ36118756-47966CA0-33EF-4906-B882-00B738E22220Q36307061-B24D02FB-0854-4A54-BBAC-312D42BD7A35Q36426708-280F9190-F00E-49E5-A560-73D9FE62A877Q36782693-839FDCC7-97D1-4134-BC3F-CBB04330D227Q36936886-EF3B8319-075B-4C38-92DD-5A6D3B284B3AQ37084935-DFC13A02-7282-4D14-95CB-82C71C5CF680Q37400889-3FC5E818-4815-4021-86C7-B4B788B4A724Q37556661-7EB726A5-CFED-467C-A72C-60557729317EQ38428629-44DC4907-9A1B-4C1A-B762-9A78B6EFC02FQ38463944-2B817F42-6D7C-4F76-9217-2BF81CAA89D1Q38506173-D92A877B-FDC1-459D-BBE2-13AF853E35B8Q39364057-36B10D0D-ECC1-40D5-A9DF-0541C73D1902Q39419188-D2A0E5F0-5A5F-4584-9CA4-043B747CA31CQ39694070-3CC2B91E-0669-484A-9094-508A9703FAC8Q39928512-4278E8C0-98D1-46B6-81AC-B1F62534B11EQ42233730-DBDDE964-4D98-4190-B812-7AEDFF579FE3
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Markku Peltonen
@ast
Markku Peltonen
@en
Markku Peltonen
@es
Markku Peltonen
@nl
Markku Peltonen
@sl
type
label
Markku Peltonen
@ast
Markku Peltonen
@en
Markku Peltonen
@es
Markku Peltonen
@nl
Markku Peltonen
@sl
prefLabel
Markku Peltonen
@ast
Markku Peltonen
@en
Markku Peltonen
@es
Markku Peltonen
@nl
Markku Peltonen
@sl
P1053
F-3037-2015
P106
P21
P31
P3829
P496
0000-0002-3767-4223